James T. Dalton
2008
In 2008, James T. Dalton earned a total compensation of $632.8K as Vice President, Preclinical Research and Development at GTX, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $77,189 |
|---|---|
| Option Awards | $200,623 |
| Salary | $311,875 |
| Other | $43,088 |
| Total | $632,775 |
Dalton received $311.9K in salary, accounting for 49% of the total pay in 2008.
Dalton also received $77.2K in non-equity incentive plan, $200.6K in option awards and $43.1K in other compensation.
Rankings
In 2008, James T. Dalton's compensation ranked 5,777th out of 9,135 executives tracked by ExecPay. In other words, Dalton earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,777 out of 9,135 | 37th |
Division Manufacturing | 2,114 out of 3,436 | 39th |
Major group Chemicals And Allied Products | 447 out of 815 | 45th |
Industry group Drugs | 289 out of 597 | 52nd |
Industry Pharmaceutical Preparations | 213 out of 408 | 48th |
Source: SEC filing on March 18, 2011.
Dalton's colleagues
We found four more compensation records of executives who worked with James T. Dalton at GTX in 2008.